Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is unchanged from the number of companies inspected in the previous quarter.
Most of the companies inspected at the time were involved in the Food and Cosmetics sector. The second most common type of company inspected worked in the Devices sector.
There were five companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Three should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
CEMI International, Inc. | Food and Cosmetics | 11/03/2023 | Voluntary Action Indicated (VAI) |
Hevener Sales, Inc. | Food and Cosmetics | 10/24/2023 | Voluntary Action Indicated (VAI) |
Nexair, LLC | Drugs | 12/06/2023 | No Action Indicated (NAI) |
Optimotion Implants, LLC | Devices | 10/20/2023 | Voluntary Action Indicated (VAI) |
PJ Food Service, Inc. | Food and Cosmetics | 11/16/2023 | No Action Indicated (NAI) |
Perimeter Global Logistics | Food and Cosmetics | 10/26/2023 | No Action Indicated (NAI) |
Scendia Biologics, LLC | Biologics | 12/19/2023 | No Action Indicated (NAI) |
Xenix Medical | Devices | 11/08/2023 | No Action Indicated (NAI) |